Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GZPHF research report →
About the company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF), operating with its various subsidiaries, is a diversified pharmaceutical conglomerate primarily engaged in the research, development, manufacturing, and global distribution of a broad spectrum of medical products. This includes traditional Chinese patented medicines, Western pharmaceuticals, chemical raw materials, natural and biological medicines, as well as chemical raw material intermediates. The company's reach extends throughout the People's Republic of China and into international markets.
- CEO
- Hong Li
- IPO
- 2010
- Employees
- 28,138
- HQ
- Guangzhou, CN
Price Chart
- Market Cap
- $6.20B
- P/E
- 11.64
- P/S
- 0.44
- P/B
- 0.87
- EV/EBITDA
- 10.23
- Div Yield
- 4.01%
- Gross Margin
- 16.00%
- Op Margin
- 4.13%
- Net Margin
- 3.75%
- ROE
- 7.70%
- ROIC
- 3.98%
- Revenue
- $75.45B · 0.61%
- Net Income
- $2.91B · 2.49%
- EPS
- $1.82 · 4.60%
- Op Income
- $3.02B
- FCF YoY
- -141.24%
- 52W High
- $2.88
- 52W Low
- $2.14
- 50D MA
- $2.26
- 200D MA
- $2.31
- Beta
- 0.25
- Avg Volume
- 39
Get TickerSpark's AI analysis on GZPHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our GZPHF coverage
Recent articles, reports, and earnings notes.
No research on GZPHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GZPHF report →Similar companies
Peers in the same neighborhood.